Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by G7 Countries: Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bone Degeneration Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 50
Contact Us 51
Source 51

List of Tables
Bone Degeneration Therapeutics, Global, Clinical Trials by Region, 2018* 7
Bone Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Bone Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Bone Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Bone Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Bone Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Bone Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 16
Bone Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Bone Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 20
Bone Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Bone Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Bone Degeneration Therapeutics, Global, Clinical Trials by Phase, 2018* 23
Bone Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24
Bone Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Bone Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2018* 26
Bone Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Bone Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 28
Bone Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Bone Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Bone Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33

List of Figures
Bone Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Bone Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Bone Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Bone Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Bone Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Bone Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2018* 15
Bone Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Bone Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Bone Degeneration to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2018* 19
Bone Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21
Bone Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22
Bone Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23
Bone Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24
Bone Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25
Bone Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 27
Bone Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 28
Bone Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29
Bone Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31
Bone Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 33
GlobalData Methodology 50

Companies Mentioned
- Novartis AG
- Vivatech International Inc
- PolyNovo Ltd
- Noray Biosciences Group
- Kaiser Permanente
- Fate Therapeutics Inc
- Citospin SL
- Celerion Inc
- Baxter International Inc
- Amgen Inc